Header cover image

U.K. (FTSE) Biotech Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
  • 7D-4.8%
  • 3M-3.7%
  • 1Y24.6%
  • YTD14.0%

Over the last 7 days, the Biotech industry has dropped 4.8%, driven by a decline by Genus of 10%. This takes the industry's 12 month performance to a gain of 25%.

Industry Valuation and Performance

Has the U.K. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021UK£11.2bUK£1.1b-UK£123,066,197.0063.1x
Tue, 26 Oct 2021UK£12.4bUK£1.1b-UK£148,329,496.0070.4x
Thu, 23 Sep 2021UK£12.5bUK£1.1b-UK£143,618,678.0054.1x
Sat, 21 Aug 2021UK£12.4bUK£1.0b-UK£172,541,949.9131.5x
Sat, 05 Jun 2021UK£11.4bUK£1.0b-UK£166,338,934.5230.7x
Tue, 09 Mar 2021UK£11.5bUK£1.0b-UK£144,713,708.8131.9x
Mon, 30 Nov 2020UK£8.8bUK£985.1m-UK£119,804,987.8160.8x
Thu, 03 Sep 2020UK£8.2bUK£992.8m-UK£138,646,257.4553.8x
Sun, 07 Jun 2020UK£8.0bUK£985.7m-UK£114,704,522.8157x
Sat, 29 Feb 2020UK£6.0bUK£946.5m-UK£54,517,543.4452.8x
Tue, 03 Dec 2019UK£6.4bUK£925.4m-UK£84,370,311.3062x
Fri, 06 Sep 2019UK£5.4bUK£898.9m-UK£95,371,524.0152.7x
Mon, 10 Jun 2019UK£6.1bUK£884.5m-UK£97,895,948.3656.9x
Sun, 03 Mar 2019UK£5.5bUK£873.1m-UK£123,682,236.4045.7x
Wed, 05 Dec 2018UK£5.3bUK£866.3m-UK£98,066,918.1660.3x
PE Ratio


Total Market Cap: UK£5.3bTotal Earnings: -UK£98,066,918.16Total Revenue: UK£866.3m0%0%0%3 Year10 Year

Current Industry PE: Investors are more optimistic on the industry, considering it's trading at a PE ratio of 63.1x which is higher than its 3-year average PE of 50.1x. It appears they are confident that earnings will grow faster in the future than they have historically.

Past Earnings Growth: The earnings for companies in the Biotechs industry have deteriorated over the last three years, while revenues for these companies have grown 7.8% per year. This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the U.K. Biotech industry?


Industry PE: Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 50.1x. However analysts are expecting annual earnings growth of 19%, which is lower than the prior year's growth of 32% per year. So the market might believe that analysts are underestimating future growth.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 19% over the next 5 years. However this is lower than its past earnings growth rate of 32% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

SNG Synairgen4.2%+UK£14.7m115.3%PB7x
SCLP Scancell Holdings1.2%+UK£2.0m76.6%PB8.7x
OKYO OKYO Pharma2.8%+UK£1.8m-13.1%PB17.5x
VAL ValiRx8.1%+UK£1.6m42.6%PB5.2x
HEMO Hemogenyx Pharmaceuticals2.3%+UK£391.9k-78.6%PB1.9x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News